Drugs in ATC Class A12CC

Up to Top Level ATC Classes

Up to A - Alimentary tract and metabolism

Up to A12 - MINERAL SUPPLEMENTS

Up to A12C - OTHER MINERAL SUPPLEMENTS

Drugs in ATC Class: A12CC - Magnesium

Tradename	Generic Name
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride

A12CC Market Analysis and Financial Projection

The global market for magnesium-based supplements (ATC Class A12CC) is experiencing robust growth, driven by increasing health awareness and diverse industrial applications. Meanwhile, the patent landscape reflects innovation in formulations and production methods to meet rising demand. Below is a detailed analysis of these dynamics:

---

Market Dynamics

Global Growth Projections

• The magnesium market is projected to grow from $5.92 billion in 2025 to $9.50 billion by 2034, accelerating at a 5.39% CAGR[1].
• Magnesium glycinate, a highly bioavailable form, is a standout segment, with its market expected to rise from $1.2 billion (2024) to $2.5 billion by 2037 (5.8% CAGR)[8].

Key Drivers

1. Health Supplement Demand:

   • Magnesium supplements saw double-digit sales growth in mainstream and natural channels, particularly for digestive health (+13%), sleep (+26%), bone health (+35%), and mood support (+24%)[3][8].
   • Recognition by institutions like the Mayo Clinic for its role in blood pressure regulation and stress management has bolstered consumer trust[8].

2. Regional Expansion:

   • Asia-Pacific dominates, accounting for over 65% of global magnesium revenue, driven by automotive and aerospace industries in China and India[1].
   • Europe (notably Germany) is a key consumer due to automotive-sector demand for lightweight alloys[1].

3. Formulation Innovation:

   • Shift toward gummies, liquids, and functional beverages (e.g., BetterYou’s magnesium-infused waters) to cater to convenience-driven consumers[8].

Regulatory and Industry Trends

• ATC Classification: A12CC includes salts like magnesium chloride, sulfate, citrate, and glycinate, widely used in pharmaceuticals and supplements[9][13].
• Magnesium stearate, a common excipient in tablets, is projected to grow at 3.8% CAGR, driven by pharmaceutical demand[4].

---

Patent Landscape

Key Patent Trends

1. Production Methods:

   • Patents like US6676824 focus on purifying magnesium chloride for electrolytic magnesium production[5].
   • WO2013125503A1 covers nitrogen-containing carbon alloys using magnesium acetate, highlighting catalytic applications[2].

2. Supplement Formulations:

   • US20140348952A1 details magnesium oxide hydrates for enhanced bioavailability in supplements[15].
   • Magtein® (magnesium L-threonate), a patented brain-accessible form, faced litigation (settled in 2024) over IP infringement, underscoring competitive R&D[16].

3. Pharmaceutical Applications:

   • Over 50% of Japan’s prescribed medications use magnesium stearate as a binding agent[4].
   • Methods for magnesium-based treatments (e.g., US10617995 for magnesium metal production) emphasize industrial scalability[5].

Legal and IP Challenges

• Patent disputes, such as ThreoTech vs. Green Jeeva, highlight the importance of protecting novel formulations like Magtein®[16].
• Regulatory hurdles include proving non-obviousness for method-of-use claims, as seen in challenges to patents like US5,965,596 (beta-alanine blends)[17].

---

Regional Market Insights

Region	Key Trends	Market Size (2025)
Asia-Pacific	Automotive and aerospace demand; generics market expansion	$3.37B (projected 2034)[1]
Europe	Focus on pharmaceuticals; Germany leads in automotive lightweight parts	$135B pharma sector (2021)[4]
North America	Health-conscious consumers drive demand for organic supplements	Leading in glycinate R&D[8]

---

Future Outlook

• Innovation: Bioavailable forms (e.g., glycinate, threonate) and novel delivery formats will dominate[8][16].
• Regulatory Focus: Stricter quality controls and patent protections to ensure efficacy and IP security[4][17].

"Magnesium’s versatility in health and industry ensures steady demand, but manufacturers must prioritize bioavailability and IP strategy to maintain growth." – Industry Analysis[1][16]

This combination of market expansion and patent activity positions magnesium (A12CC) as a critical player in both healthcare and industrial sectors.

References

1. https://www.precedenceresearch.com/magnesium-market
2. https://patents.google.com/patent/WO2013125503A1/en
3. https://www.nutritionaloutlook.com/view/magnesium-is-well-established-and-trusted-across-multiple-categories
4. https://www.coherentmarketinsights.com/industry-reports/magnesium-stearate-market
5. https://patents.justia.com/patents-by-us-classification/205/404
6. https://www.grandviewresearch.com/industry-analysis/metal-magnesium-market
7. https://patents.google.com/patent/JPH04234844A/en
8. https://www.researchnester.com/reports/magnesium-glycinate-market/4541
9. https://atcddd.fhi.no/atc_ddd_index/?code=A12CC
10. https://www.drugpatentwatch.com/p/generic-api/magnesium+sulfate
11. https://en.wikipedia.org/wiki/ATC_code_A12
12. https://pubchem.ncbi.nlm.nih.gov/compound/1309-48-4
13. https://www.atccode.com/A12CC
14. https://th.wikipedia.org/wiki/ATC_%E0%B8%A3%E0%B8%AB%E0%B8%B1%E0%B8%AA_A12
15. https://patents.google.com/patent/US20140348952A1/ru
16. https://nutraceuticalbusinessreview.com/threotech-magtein-magnsium-l-threonate-patent-infringement-settlement-green-jeeva
17. https://ipwatchdog.com/2018/09/24/ipatent-protection-pharmaceuticals-dietary-supplements/id=101364/
18. https://www.medicines.org.uk/emc/product/11577/smpc